---
title: Pure Steam Technologies | Veolia Water Technologies
description: Ensure compliance, efficiency, and cost reduction in pharmaceutical production with PolarisTM 2.0. Generate pure steam and hot water for injection, meeting quality standards. Improve safety and reliability. Find out more!
---

[![Veolia logo](https://campaign.veoliawatertechnologies.co.uk/hubfs/vwt-global/images/header-logo-capsule.png "Veolia logo")](https://www.veoliawatertechnologies.co.uk/)

[Back to the Hub page](https://campaign.veoliawatertechnologies.co.uk/pharmaceutical-hub?hsLang=en)

# PolarisTM 2.0 to support your needs

- [Contact an expert](https://www.veoliawatertechnologies.co.uk/polaris-contact-form)

The critical issues that a **pharmaceutical** and **biotechnology** company faces include the need to **ensure compliance with severe quality** and **safety standards** required by the authorities, **the efficient management** of complex production processes, the constant **control of contamination** and **the reduction of operating costs**. Furthermore, the guarantee of a constant supply of hot water for injection and pure apyrogenic steam is essential to **maintain the integrity of sensitive manufacturing processes** and **to ensure the safety and effectiveness of products intended for human use**.

![Polaris cluster 5](https://campaign.veoliawatertechnologies.co.uk/hs-fs/hubfs/Europe%20TDS/Pharma/Polaris%202.0/Polaris%20cluster%205.png?width=900&height=380&name=Polaris%20cluster%205.png)

To meet these needs, Veolia Water Technologies has developed the new generation of **PolarisTM 2.0**, composed of a **multiple effect distillation system** (MED - Multiple Effect Distiller) for the production of **hot water for injection** and a system for the **generation of pure apyrogenic steam** (PSG - Pure Steam Generator).

The new PolarisTM 2.0 range has been designed to provide the necessary volumes of water for injection and pure steam, **in line with** **European, Japanese and US pharmacopeia standards**, and includes a set of standard models with different capacities and a list of options designed to satisfy every clients’ requirement. In addition, the new PolarisTM 2.0 units are **compliant with the guidelines FDA CFR 21 Part 11 and GAMP V**.

With PolarisTM 2.0, pharmaceutical companies can be sure of using **reliable and innovative products** for the production of pure apyrogenic steam and hot water for injection. Investing in PolarisTM 2.0 means adopting an approach oriented towards **quality** and **regulatory compliance**, ensuring **maximum safety** and **reliability** in the pharmaceutical production process.

### Do you want to learn more?

Discover the benefits of the Polaris 2.0 MED and PSG units, click below to read more:

[Read Now](https://www.veoliawatertechnologies.co.uk/news/veolia-water-technologies-launches-polaris-20-pharmaceutical-wfi-and-pure-steam)

[Cookie Policy](https://www.veoliawatertechnologies.co.uk/cookie-policy)

[Terms & Conditions](https://www.veoliawatertechnologies.co.uk/legal-0)

[Privacy policy](https://www.veoliawatertechnologies.co.uk/privacy-policy)

[Modern Slavery Statement](https://www.veoliawatertechnologies.co.uk/modern-slavery-and-human-trafficking-statement)